These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells. Burga RA; Nguyen T; Zulovich J; Madonna S; Ylisastigui L; Fernandes R; Yvon E Cytotherapy; 2016 Nov; 18(11):1410-1421. PubMed ID: 27421740 [TBL] [Abstract][Full Text] [Related]
13. NK cell-based immunotherapy for cancer. Fang F; Xiao W; Tian Z Semin Immunol; 2017 Jun; 31():37-54. PubMed ID: 28838796 [TBL] [Abstract][Full Text] [Related]
14. Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma. Kamiya T; Chang YH; Campana D Cancer Immunol Res; 2016 Jul; 4(7):574-81. PubMed ID: 27197065 [TBL] [Abstract][Full Text] [Related]
15. A New Ex Vivo Method for Effective Expansion and Activation of Human Natural Killer Cells for Anti-Tumor Immunotherapy. Yang H; Tang R; Li J; Liu Y; Ye L; Shao D; Jin M; Huang Q; Shi J Cell Biochem Biophys; 2015 Dec; 73(3):723-9. PubMed ID: 27259316 [TBL] [Abstract][Full Text] [Related]
16. Clinical utility of natural killer cells in cancer therapy and transplantation. Knorr DA; Bachanova V; Verneris MR; Miller JS Semin Immunol; 2014 Apr; 26(2):161-72. PubMed ID: 24618042 [TBL] [Abstract][Full Text] [Related]
17. Current Perspectives on "Off-The-Shelf" Allogeneic NK and CAR-NK Cell Therapies. Heipertz EL; Zynda ER; Stav-Noraas TE; Hungler AD; Boucher SE; Kaur N; Vemuri MC Front Immunol; 2021; 12():732135. PubMed ID: 34925314 [TBL] [Abstract][Full Text] [Related]
18. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy. Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860 [TBL] [Abstract][Full Text] [Related]
19. Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities. Hu W; Wang G; Huang D; Sui M; Xu Y Front Immunol; 2019; 10():1205. PubMed ID: 31214177 [TBL] [Abstract][Full Text] [Related]
20. Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell. Lin C; Zhang J Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):200-215. PubMed ID: 29378229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]